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ABSTRACT
3-Nitrofluoranthene (3-NFA) and 2-Nitrofluoranthene are
environmental pollutants created during combustion processes,
proven to be mutagenic in bacterial assays and potentially
carcinogenic in mammalian species. The binding of electrophilic
metabolites of a nitro-PAH to DNA may lead to mutagenicity and
carcinogenicity. This study shows that rat hepatic enzyme systemsin S9 are able to catalyze the binding of 3-NFA (labeled with ^^C)and 2-NFA (labeled with ^H) to calf thymus DNA in vitro. Maximum
activity (800-1500 pmole 3-NFA/mg DNA in 1 hour) for 3-NFA occurred
in incubations conducted under air and with S9 and NADPH. When NADH
was used as a cofactor less activity was obtained (200-500 pmole
3-NFA/mg DNA in 1 hour) . The converse held true for 2-NFA as
greatest activity occurred under air and with S9 but with NADH
(1.1-1.25 pmole 2-NFA/mg DNA in 1 hour). DNA-bound radioactivity
was less with NADPH in similar conditions (0.6-0.8 pmole 2-NFA/mg
DNA in 1 hour) . Addition of other cofactors (FAD and FMN in
addition to NAD and NADPH) showed insignificant levels of binding
for either isomer. SKF 525A was unable to inhibit DNA binding of
both compounds. Addition of glutathione had no effect in
incubations with 3-NFA but seem to enhance the DNA binding of 2-
NFA. These results indicate the participation of cytochrome P-450
in the oxidative metabolism of 3-NFA and possibly 2-NFA.
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I. Introduction
Nitrated polycyclic aromatic hydrocarbons (PAHs) including
3-nitrofluoranthene (3-NFA) and 2-nitrofluoranthene
(2-NFA) are widespread environmental pollutants which may play a
role in the etiology of human cancer.  Nitrogen oxides (e.g.
NgOj, HNO3 and NOj*) produced during combustion react with PAHs
also present in the combustion gases to produce nitro-PAHs
(Zielinska et al, 1986). 3-NFA is readily produced from the
direct nitration of fluoranthene under many conditions
particularly in combustion emissions (Kamens et al, 1984).  2-NFA
prevails in ambient air (Pitts et al, 1985; Schuetzle et al,
1982) and is formed by an indirect mechanism initiated by the
attack of a hydroxyl radical at the C-2 position (Zielinska et
al, 1986).  3-NFA and 2-NFA have been reported to be potent
bacterial mutagens (Ball et al, 1986; Stocking, 1989) and
possibly carcinogens in mammalian assays (DiPaola et al, 1983 ;
Rozenkranz et al, 1982).
Nitro-PAHs require metabolism to reactive electrophiles to
exert their biological effects.  Partial reduction of the nitro
function to the hydroxyl amines or oxidation of the aromatic
rings to epoxides are the two proposed metabolic pathways.
Historically, the former pathway has been considered the
predominant route in mutagenicity and DNA adduct formation for
2nitro compounds (Miller et al, 1977).  This process is thought to
proceed via the active arylnitrenium electrophile.  3-NFA and 2-
NFA were reduced by bacterial systems and demostrated mutagenic
behavior (Stocking, 1989).  Xanthine oxidase, a cytosolic
nitroreductase, catalyzed the in vitro metabolism of 3-NFA to DNA
adducts (Howard et al, 1988; Dietrich et al, 1988).  However, the
oxidized metabolites of these isomers in vitro also were able to
display mutagenicity (Console et al, 1989; Zielinska et al,
1988).  Although there is no causal relationship between
mutagenicity and DNA binding, both events occur from the type of
interactions with genetic material which are thought to lead to
genotoxic damage to the animal.
This study evaluates the ability of hepatic enzyme systems
to catalyze the formation of metabolites capable of interacting
with DNA and determines whether these reactions can be linked to
oxidative or to reductive metabolism.  Also, the involvement of
the cytochrome P-450 system and other enzymes known to be
particularly active in the metabolism of xenobiotics was studied.
Specifically, various cofactors, NADP, NAD, FAD and FMN, an
inhibitor of cytochrome P-450, SKF 525A, and glutathione were
added to elucidate the pathways responsible, singly or in
conjunction, for the catalysis of in vitro binding of 3-NFA and
2-NFA.
II. Literature Review
A.Nitro-PAHs in the Environment
1.Occurrence in the Atmosphere
Although the presence of polycyclic aromatic hydrocarbons
(PAHs) in polluted air is well established, it is now appreciated
that the genotoxicity of urban air is greater than that which can
be solely attributed to PAHs (DiPaolo et al, 1983).  Research in
recent years has suggested that nitro-PAHs also play an important
role. 3-nitrofluoranthene (3-NFA) and 2-nitrofluoranthene (2-NFA)
are two such isomers (Fig.l).  These nitro-PAHs endanger the
human population as they have been found to be highly mutagenic
(Mermelstein et al, 1981) and potentially carcinogenic (Oghaki et
al, 1982; Lewtas et al, 1983).  Significant levels of these
compounds have been reported to be in fly ash, diesel exhaust,
photocopier fluids, cigarette smoke and air samples (DiPaolo et
al, 1983). The primary source of exposure to 3-NFA is through
combustion emissions such as diesel exhaust (Pitts et al, 1985;
Gibson et al, 1982; Nishioka et al, 1982). 2-NFA, however, has
been detected mainly in urban air (Pitts et al, 1985). Recently,
it has been demonstrated to be the most abundant nitrated
fluoranthene in organic extracts of the ambient air particulate
matter collected in Philadelphia (Sweetman et al, 1986; Arey et
al, 1986; Pitts et al, 1985) and in Southern California
(Schuetzle et al, 1982).
2.Formation of Nitro-PAHs
Nitro-PAHs including 3-NFA and 2-NFA are found when products
of PAHS, oxides of nitrogen and traces of organic acid are
present concurrently (Rosenkranz and Mermelstein, 1983).  This
can occur either in emissions from combustion sources or while
circulating in ambient air (fig. 2) (Nielsen et al, 1983).
3-NFA is readily produced from the nitration of
fluoranthene.  It results from direct nitration by dinitrogen
pentoxide (N2O5) , nitric acid (HNO3) or NO^*.  These nitrogen oxide
species also produced during combustion, react with 3-NFA in
either a free radical or ionic mechanism to produce a nitro-PAH
(Zielinska et al, 1986; Kamens et al, 1984).  Gaseous pollutants
such as NOj and HNOj are expected to react with electrophilic
centers at the carbon atoms of highest electron density on the
PAH (van Cauvenberghe et al, 1983).
2-NFA, however, appears to be formed from fluoranthene in
the ambient air by a specific transformation mechanism (Zielinska
et al, 1987). It is believed that the fluoranthene reacts with
NjOg after the initial free radical formation (Pitts et al, 1985;
Zielinska et al, 1986) or addition of an hydroxy radical at the
site of highest electron density (Nielsen et al, 1984).
Figure 2 shows the structure of fluoranthene and its major
products of nitration from combustion and atmospheric reactions.
Photodegradation may alter nitro-PAHs. This involves
rearrangement of the nitro-PAH to the corresponding aryl nitrite
and subsequent formation into NO and a phenoxy-type radical
5(Nielsen et al, 1983).  Other factors may also influence the
formation and decomposition of nitro-PAHs.  These include:
temperature, sunlight, ozone concentration, surface
characteristics of the particulate and polarity of the reaction
medium (Nielsen et al, 1983; Nielsen et al, 1984; Zielinska et
al, 1986).
B.Xenobiotic MetsUaolism
1. General MetzUsolism
Animal organisms have developed a number of biochemical
processes that convert lipophilic compounds to more hydrophilic
metabolites.  The ease with which toxins are eliminated depends
on their water solubility.  Enhanced water solubility leads to
reduction in the compound's ability to partition into biological
membranes restricting its distribution to the various tissues,
decreasing renal tubular and intestinal reabsorption and
ultimately promoting the excretion of the chemical by urinary and
biliary routes (Caldwell and Jakoby, 1983).  Ironically, the same
systems which detoxify can also toxify.
The transformation of xenobiotics can take place both in the
microsomal and non-microsomal fractions and are of two types:
phase I and phase II. In phase I the conversion of lipophilic to
more polar takes place. The hydrolytic reactions, non-microsomal
oxidations/reductions, and microsomal oxidation/reductions are
regarded as phase I reactions. A prime function of these
reactions is to add or expose functional groups (e.g. -OH,—SH, -
6NHj _and -COOH) . In phase II, conjugation modifies the more polar
phase I molecule at the site of activation if the phase I
molecule is not already excreted or further metabolized by phase
I type reactions (deBethizy and Hayes, 1989).  Once conjugated
metabolites are so polar they cannot redistribute and are left to
excretion without recourse.
2. Oxidative Metabolism
a.Microsomal Oxidation
The most important enzyme system involved in phase I
reaction are the cytochromes P-450 monooxygenases.  Cytochromes
P-450 have been found in the hepatic endoplasmic reticulum of
many species. There are a wide variety of cytochrome P-450
isozymes in the cell, each of which have different substrate
specificities and which catalyze different types of reaction;
mainly the introduction of Oj into xenobiotic. Consequently,
different P-450 have been given different names, depending upon
substrate, gene inducer and organism (Young and Lu, 1987).  In
rat liver alone, at least, ten isozymes of P-450 have been
isolated with UV absorption maxima ranging from 447-452 (Lu et
al, 1980; Schwab et al, 1987).
The key enzymes associated with the cytochrome P-450
electron transport systems are:  cytochrome P-450 (a
hemeprotein), NADPH-dependent cytochrome P-450 reductase (a
flavoprotein), cytochrome b5 (a hemeprotein) and NADH-dependent
b5 cytochrome reductase (a flavoprotein).  These enzymes are
7either embedded in the phospholipid matrix of the smooth
endoplasmic reticulum or rest on its periphery. In vitro the
cytochromes P-450 exists as a membrane-bound enzyme complex
located on and within the membrane of the microsome (Lu et al,
1974). The ratio of enzymes varies depending upon the species and
induction state of the liver.  In rat liver, the ratio of
cytochrome P-450, cytochrome bj and their corresponding
reductases is 20:12:1:1 respectively.
Figure 3 illustrates the cytochrome P-450 electron transport
systems. Basically, the mixed function oxygenase (MFO) system
functions as a electron transport chain and an active site. The
substrate combines with the oxidized P-450 (Fe*^) and forms a
complex.  This complex accepts an electron from NADPH cytochrome
P-450 reductase and reduces the iron.  The reduced complex
combines with molecular oxygen and then accepts another electron
from either NADPH or NADH via NADPH cytochrome P-450 reductase or
NADH cytochrome bg reductase. Both electrons are transferred to
the oxygen molecule by an unclear mechanism.  The resulting
complex is highly reactive and unstable. One oxygen atom of this
reactive species binds to the substrate and the other produces
water.  The substrate dissociates and renders the oxidized
cytochrome P-450 free and ready to repeat the cycle (Casarett,
Doull and Amdur, 1986).
The system is further complicated in that cytochrome bg and
its reductase can receive electrons from both NADH and NADPH
reductase (Sato and Omura, 1978).  Bilimoria and Kamin (1973)
8demonstrated that the direct reduction of cytochrome reductase
was possible in the microsomal fraction.  Because of this
reactivity with cytochrome bg, NADPH cytochrome reductase may
serve as an electron donor for all reactions in which cytochrome
bg are involved as electron donors (Schenkman and Kupfer, 1982).
It was previously suggested that the stimulation of NADPH
dependent oxidations by NADH was due to a more efficient supply
of electrons to the oxygenated form of the reduced cytochrome P-
450 (Sato and Omura, 1978). Therefore, the participation of
cytochrome bg could contribute a synergistic effect.
In conclusion all electrons for the microsomal transport
system are derived from either NADH or NADPH through their
flavoproteins, NADH cytochrome bg reductase and NADPH cytochrome
P-450 reductase. The electrons travel from these two paths to
multiple terminal electron acceptors and are utilized in various
metabolic reactions which require the supply of reducing
equivalents (Sato and Omura, 1978).
b.Nitro-PAHs
Most nitro-PAHs are biologically inert and require
metabolism to a reactive electrophile to exert their biological
effects.  The biological effects and metabolic transformations of
3-NFA and 2-NFA are in the initial steps of research and,
subsequently, much remains unknown.  Numerous investigators have
characterized l-NP (Rosenkranz et al, 1980; Scheutzle et al,
1982; Mermelstein et al, 1981; Howard and Beland, 1982; Ohgaki et
9al, 1982; Hirose et al, 1984).  It resides in the ambient air,
photocopier toners and diesel emissions (Rosenkranz et al, 1980;
Scheutzle et al, 1982; Gibson et al, 1982).  1-NP is highly
mutagenic (Mermelstein et al, 1981) and carcinogenic (Hirose et
al, 1984).  Furthermore, this compound undergoes both reductive
and oxidative metabolism and is activated by both bacterial and
mammalian enzymes (Howard and Beland, 1982).  The biological
effects of 3-NFA and 2-NFA are expected to be similar to their
well characterized isomer 1-NP (Fig.l).
Nitro-PAHs can undergo oxidative metabolism resulting in the
epoxidation and hydroxylation of the aromatic ring catalyzed
mainly by cytochromes P-450 (Ball and Lewtas, 1985).  Incubation
of 1-NP with liver and lung microsomes produced several
metabolites including 6-hydroxy-l-nitropyrene, 8-hydroxy-l-
nitropyrene, 3-hydroxy-l-nitropyrene, 1-nitropyrene trans-9,10-
dihydrodiol and l-nitropyrene-4,5-oxide (Djuric et al, 1986; King
et al, 1987; Ball et al, 1984). Rabbit tracheal epithelial cells
treated with 1-NP formed several hydroxy 1-nitropyrenes (King et
al, 1987).  These metabolites reduced more readily than the
parent compound emphasizing their potential importance in the
role of in vitro production of DNA adducts (Djuric et al, 1986).
Several investigators incubated 3-NFA with Aroclor 1254
treated rat liver S9 fraction (Ball et al, 1985; Kirshner, 1988;
Howard et al, 1988).  Ball et al (1985) observed six hydroxy
metabolites. Continuation of this work showed that the major
metabolites produced were 9-,10- and 8-hydroxy-3-
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nitrofluoranthene (Kirshner, 1988).  Howard et al (1988) also
identified and isolated metabolites produced from in vitro
incvibations with either untreated or Aroclor 1254 induced rat and
guinea pig microsomes.  The major metabolites produced in the rat
liver were 8-and 9-hydroxy-3-nitrofluoranthene while the guinea
pig fraction produced mainly 6-hydroxy-3-nitrofluoranthene.  All
microsomal preparations had minor concentrations of l-hydroxy-3-
nitrofluorathene.
The major metabolites of 2-NFA upon incubation with Aroclor
1254 rat induced S9 were 8-and 9-hydroxy-2-nitrofluoranthene (
Zielinska et al, 1986).  Ball et al (1987) also identified 5,6-
dihydrodiol and 2-nitrofluorathene 8, 9-dione.  Formation of 8-
and 9-hydroxy-2-nitrofluoranthene is thought to occur either by
epoxidation followed by symmetric rearrangement or by the
formation of phenols through direct hydroxylation at the distal
end of the molecule (Ball et al, 1987).  Unlike 1-NP under
similar conditions but like 3-NFA no products of nitroreduction
were observed. This is important as it suggests another route for
potential damage e.g. epoxidation of the aromatic rings (Ball et
al, 1987). Subsequent generation of the reactive electrophiles
could interact with cellular nucleophiles and lead to genotoxic
damage.
3. Reductive Metabolism
a.General Reduction
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Metabolism and mutagenicity in both mammalian and bacterial
cell systems appears to depend on the reduction of nitro-PAHs.  A
schematic pathway has been proposed (Patton et al, 1986) for both
3-NFA and 2-NFA.  Generally, figure 4 and 5 illustrate the
reduction from the nitro-PAH to the nitroso PAH to the N-
hydroxylamine and ultimately to the fully reduced amino PAH.
Under acidic conditions the N-hydroxylamine can be converted to
an arylnitrenium ion which is a reactive electrophile.  Further
rearrangement of this ion produces a carbonium ion which is also
highly electrophilic.  Both electrophiles are capable of reacting
with DNA.
b.Bacterial-mediated Reductions
Bacterial systems such as Salmonella typhimurium as well as
mammalian gut flora seem to rely solely on nitroreduction in the
metabolism of nitro-PAHs (Howard et al, 1983a).  To date there
have been three nitroreductases identified in Salmonella: A, B
and C.  The "classical" nitroreductase B accounts for 94% of the
activity in strain TA 98 of 1-NP (Bryant et al, 1983).
Hydroxyarylyamines and arylnitrenium ions are electrophiles found
in the bacterial systems as a result of nitroreductase B (Howard
et al, 1983a).  The non-enzymatic dehydration of the protonated
form of the hydroxyarylamines produces the arlynitrenium ions
(Vance and Levin, 1984).  The intermediate electrophile
covalently binds to DNA at the C-8 position of guanine (Howard et
al, 1983b). Generally the bulky adduct displaces the base,
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swivels into the plane of the helix and causes a frame shift
(McCoy et al, 1981).  Incubations conducted with 1-nitropyrene
and Salmonella frameshift tester strain TA 1538 produced adducts
identified as N-(deoxyguanosin-8-yl)-1-aminopyrene (Howard et al,
1983b).
Several investigators characterized the bacterial metabolism
of 1-NP (Messier et al, 1981; Howard et al, 1983a; Ball and King,
1985; Mermelstein et al, 1981).  In the Ames assay Salmonella
typhimurium strain TA 98, 1-NP produces two major metabolites, 1-
aminopyrene and N-acetyl-1-aminopyrene, and six minor metabolites
(Messier et al, 1981). Howard et al (1983a) also identified 1-
aminopyrene in bacterial suspensions from rat intestines treated
with 1-NP.  Ball and King (1985) showed that germ-free rats dosed
with 1-NP excreted less of the reduced metabolites than rats with
normal gut flora. This indicates that the gut flora plays an
essential role in reduction.  Reduction of 1-NP to 1-aminopyrene
is believed to occur simultaneously with binding to DNA in
Salmonella TA 98 (Messier et al, 1981; Howard et al,1983a).
Although no binding occurred with the parent unmetabolized
compound, the reduced metabolites displayed binding activity
(Mermelstein et al, 1981). Both 1-nitrosopyrene and 1-NP
incubated with Salmonella tvphimurium strain TA 1538 produced a
major adduct, N-(deoxyguanosin-8-yl)-1-aminopyrene (Helfich et
al, 1985).  1-Nitrosopyrene demonstrated a faster mutation rate
and higher mutation frequency than stains treated with l-NP under
the same conditions. 1-nitrosopyrene, therefore, is recognized as
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the.inteinmediate in the pathway of mutagenic activation or, at
least, is closer to the ultimate active form.
Little information exists on the bacterial metabolism of
3-NFA and 2-NFA.  Stocking (1989) incubated 3-NFA with strains TA
98 and its variants TA 98NR and TA 98/l,8-DNP6 and observed one
metabolite, 3-AFA.  Although all three strains produced equal
amounts of metabolite over the incubation period the strain
deficient in the nitroreductases formed the metabolite at a
slower rate.  Mutagenicity studies with strain TA 98/l,8-DNP6
showed lower mutagenicity (Stocking,1989).  These results matched
Ball's et al (1985) earlier findings. They found low activity in
strains with nitroreductases but without the transacetylase
enzyme (Ball et al, 1985).  Ball et al (1985) suggested that an
additional step of transacetylation or an alternative metabolic
pathway may also contribute to the mutagenicity. In comparison to
1-NP the mutagenicity of 3-NFA and its phenolic metabolites were
also less dependent on nitroreductase (Console et al, 1989) .
Recently investigators demonstrated the bacterial-mediated
reduction of 2-NFA (Zielinska et al, 1987; Stocking, 1989).
Stocking (1989) identified two reduced metabolites and determined
that the mutagenic activity was 5 to 15 fold less than 3-NFA.
Zielinska et al (1987) showed that the bacterial activation of 2-
NFA required nitroreduction to produce the N-hydroxyarylamine.
Furthermore, they demonstrated that in the presence of S9 the
reduction 2-NFA was only moderate indicating that epoxidation was
not the predominant activating process.
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c.Reduction Mediated by Heunmalian Enzymes
Reductive metabolism of nitro-PAHs can also take place in
eukaryotic cells.  Although nitro reductase enzymes in mammals
are only present at low level (Karpinsky et al, 1982) they exist
in both the cytosol and the endoplasmic reticulum ( Howard et al,
1982; Fouts et al, 1954).  Shigeyuki et al (1983) showed that
rabbit liver microsomes and cytosolic enzymes were able to reduce
1-NP and 2-nitrofluorene (2-NF) to their corresponding amines
under anaerobic conditions. They suggested that the enzymes
located in the cellular fraction vary from the enzymes in the
extracellular fraction. Studies conducted with p-nitrobenzoic
acid illustrate that the supernatant and microsomal fractions
display different properties with respect to inhibition by Oj and
stimulation by phenobarbital.  Furthermore, it was demonstrated
that NADH-linked reduction was negligible in the microsomes and
effective in the soluble fraction, whereas the converse held true
for NADPH (Kato et al, 1969). Currently the enzymes identified in
the soluble fraction responsible for nitroreduction are xanthine
oxidase (XO), aldehyde oxidase (AO) and Dt-diaphorase (Howard et
al, 1982) .
XO is one of the major cytosolic enzymes capable of
nitroreduction (Howard and Beland, 1982).  Morita et al (1971)
established that it can catalyze the reduction of a number of
nitro compounds as well as NAD, artificial dyes (methylene blue),
ferriccynanide, quinones, nicotinamide and nitrofurans.
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Normally, this system catalyzes the 2 electron oxidation of
hypoxanthine (a product of purine base deamination) to xanthine
and then to uric acid which is excreted (Lehninger 1975; Morita
et al, 1971) (Fig.6).  Nitroaromatic compounds displace the
system's nomnal cofactor NADH, act as the electron acceptor and
become reduced (Howard and Beland, 1982).  The reduced nitro
compounds, N-hydroxy and amine derivatives, can bind covalently
to cellular nucleophiles like DNA and protein (Howard et al,
1983b). Howard et al (1983b) demonstrated the DNA binding of 1-NP
catalyzed by XO.  Edwards et al (1986) showed that XO induced the
formation of 1 minor and 1 major DNA adduct from 1-NP.
Furthermore, DNA binding required the presence of hypoxanthine
and was inhibited with the addition of allopurinol (Howard et al,
1982). The reduction 3-NFA by XO in the presence of DNA
consequentially formed DNA adducts (Dietrich et al, 1988).
Some mammalian tissues contain another hydroxylating enzyme
aldehyde oxidase (AO). AO has an internal electron transport
system which like XO is capable of functioning with a wide
variety of electron acceptors (Wolpert et al, 1973).  Both
flavoproteins reduce Oj, various dyes and cytochrome c; both
catalyze the oxidation of a series of aldehydes; and both
catalyze the oxidation of the carbon adjacent to a nitrogen atom
in aromatic heterocyclic compounds (Rajagopalan et al, 1962).
Purification studies show that both enzymes have similar
molecular weights near 300,000 and contain iron, molybdenum and
FAD (Rajagopalan et al, 1962).
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Despite the similarities of these enzymes, AO remains an
unique flavoprotein in comparison to XO. It is inhibited by
menadione and accepts electrons from FAD (Wolpert et al, 1973 and
McLane et al, 1983). Furthermore, AO also has an additional
component identified as coenzyme Q-like quinone (Krenitsky et al,
1972).  Rajagopalan et al (1962) suggest that this quinone
intimately associates with the enzyme thereby participating in
its oxidative function.
Little is known about the metabolic role of AO.  Because of
its vast similarities with XO it is thought to behave similarly
to XO; especially in its ability to utilize organic nitro
compounds as electron acceptors (Wolpert et al, 1973).  Although
XO and AO readily catalyze the oxidation of substituted
pyrimidine structures, oxo-substituted heterocycles as well as
aldehydes, their specificities do not overlap (Rajagopalan et al,
1962).  Rajagopalan et al (1962) suggest that AO is a "form of
XO".  Krenitsky et al (1973) support this claim by demonstrating
that both enzymes oxidize a broad spectrum of compounds and notes
that their specificities complement.  Compounds, therefore, not
oxidized by the one enzyme were readily oxidized by the other.
DT-diaphorase is another cytosolic enzyme involved in
nitroreduction. It is a highly sensitive to inhibition by
dicoumarol and is capable of catalyzing the oxidation of NADH and
NADPH by various quinones and redox dyes (Lind et al, 1980).
Lind and Ernster (1974) suggested that the enzyme serves as a
quinone reductase in connection with conjugation of hydroquinones
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during detoxification and metabolism of vitamin K.  In contrast
to other reductases, the two electrons obtained from the
nucleotides can be transferred simultaneously rather than in
sequential single electron steps (McLane et al, 1983).  It,
therefore, is assumed that DT-diaphorase reduces the substrate
directly to a hydroquinone bypassing its semiquinone radical
intermediates.  Treatment of rats with PAHs known to induce MFO
system increased hepatic DT-diaphorase (Lind and Ernster, 1974).
Other inducers of the MFO system e.g.phenobarbital and 3-
methylcholanthrene had similar effects (Lind and Ernster, 1974).
Lind and Ernster (1974) therefore, proposed a functional
relationship between DT-diaphorase and the MFO system.  They
hypothesized that DT-diaphorase might act as either the
cytochrome P-448 reductase component of the MFO system or be a
necessary component in the induction of MFO caused by 3-
methylcholanthrene.  The underlying reaction mechanism and the
exact physiological function of these enzymes are unknown and
merit further study.
Figure 7 is an illustration of a hypothetical hepatocyte. In
parenthesis next to each organelle's name are the enzyme systems
associated with that particular organelle. Table 1 is a list of
the specific enzyme systems examined in this study.
d.Microsomal Reduction
Even though the microsomal cytochrome P-450 is classed as an
oxygenase it can also catalyze the reductive biotransformation of
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certain xenobiotics.  The enzymes involved in these reactions are
believed to be NADPH cytochrome P-450 reductase and cytochrome
P-450 (Hewich et al, 1982). These reactions thrive under
conditions of low oxygen.  The substrate rather than molecular
oxygen accepts the electron and becomes reduced.  Nitro-PAHs
accept reducing equivalents and the nitro group ultimately
results as an amine (Mermelstein et al, 1981). "The very low
redox potential, broad substrate specificity and strong ligand
binding of these systems allow the donation of electrons to
electron accepting xenobiotics, which results in a reduction
rather than the predominant oxidative biotransformation"
(Casarett, Doull and Amdur, 1986).
Several investigators reported nitroreductase activity in
rat hepatic microsomes (Petersen et al, 1979; Ball et al, 1984;
Djuric et al, 1986).  Ball et al (1984) identified l-aminopyrene
in vitro with 1-NP and rat liver microsomes.  Bond et al (1984)
observed nitroreduction of 1-NP followed by N-acetylation to form
acetylaminopyrene in perfused rat liver. Belisario et al (1990)
confirmed the involvement of cytochrome P-450 in the reductive
metabolism of 3-NFA. They demonstrated a decrease of 3-NFA
reductase activity when cytochrome P-450 inhibitors ( CO and SKF
525A) were present. Also they noted an increase of nitroreductase
activity in microsomes from rats pretreated with phenobarbital.
C.Conj ugation
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The electrophilic species produced by phase I enzymes can
bind to DNA forming covalent adducts which are the precursors to
mutations.  Phase II enzymes, however, represent a major pathway
for removing electrophiles from the cell.  These
biotransformation reactions are characterized by the transfer and
covalent attachment of a small endogenous molecule e.g. inorganic
sulfate, glucuronic acid, methione and glutathione onto a
xenobiotic or its metabolite.  The conjugate devoid of
pharmacological activity can then be readily eliminated by the
biliary or renal routes (fig. 8).
One such conjugation reaction is with glutathione (GSH).
Glutathione is a tripeptide containing a gamma-glutamyl linkage
and a thiol function.  Glutathione conjugation is the formation
of a thio ether between the GSH and a compound with an
electrophilic center.  These reactions are mediated by a family
enzymes called glutathione-S-transferases. They been identified
and isolated from the cytosol of rat liver and to a lesser extent
in the microsomal fraction (Jakoby et al, 1978).  Glutathione-S-
transferase initiates the first step of detoxification by
catalyzing the attachment of GSH on the electrophilic carbon site
(Sies and Wendel, 1978).  The GSH conjugate is, subsequently,
cleaved to cysteine derivatives which are then acetylated to N-
acetylcysteine (mercapturic acid) conjugates.  Mercapturic acid
conjugates are then readily excreted into the urine (Casarett,
Doull and Amdur, 1986).
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Although there are many compounds which can provide a
sufficient electrophilic carbon site for GSH conjugation, nitro
PAHs are of specific concern- Polycyclic aromatic hydrocarbon
derivatives may be metabolized through epoxidation to reactive
intermediates capable of reacting with GSH.  Djuric et al (1986)
identified and isolated GSH conjugates of 1-NP metabolized from
epoxide intermediates. Hesse et al (1980) studied the
relationship of GSH in the possible inhibition of DNA binding.
They incubated benzo(a)pyrene with hepatic nuclear and cytosolic
fractions of untreated rats and found a decrease in DNA-bound
metabolites.  In other studies they were able to restore DNA
binding with the addition of treated cytosol which contained no
GSH. Hesse et al (1982) confirmed their former observations by
demonstrating that inhibition of binding of BP-7,8-diol
metabolites to DNA was mediated by GSH transferase.  Malaveille
et al (1980) showed that the addition of GSH in liquid assays
produced greater BP mutagenicity than the incubations conducted
in the absence of GSH. They attributed the increased effect to
selective conjugation of simple oxides with GSH, which may
compete with BP 7,8-oxide for epoxide hydratase. BP 7,8-oxide
would be converted to a diol and eventually to a highly reactive
7,8-dihydrodiol 9,10-oxide.
Although epoxidation occurs with PAHs, nitro aromatics are
also readily reduced to their corresponding amines. In the
sixties the Millers (1977) demonstrated that some aromatic nitro
amine derivatives were more carcinogenic than the parent
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compound.  They conducted experiments with 2-acetylaminofluorene
and found its metabolite N-hydroxy-2-acetlyaminofluorene to form
DNA adducts (Miller et al, 1977). Meernam and Tijdens (1985)
pretreated animals with chemicals to deplete hepatic GSH prior to
the administration of N-hydroxy-2-acetylaminofluorene.  They
monitored the extent of DNA binding and observed no increase DNA
binding activity despite the increase in hepatoxicity and
decrease in excreted GSH conjugates. Studies conducted with
bladder cancer and 2-naphthylamine showed that the N-hydroxy
metabolite binds to DNA. These investigators, however, noted no
GSH conjugates (Kadlubar and Hammons, 1967).
Nitro aromatic nitroso derivatives can bind to GSH. In
studies with 2-nitrosofluorene and GSH, Mulder et al (1982)
reported two conjugates. However, they were unable to show any
appreciable decrease in binding to DNA in the presence of GSH.
Yamazoe et al (1986) studied the aromatic aminoazo dye, N,N-
dimethyl-4-aminobenzene, in vitro and found that DNA binding
decreased with the addition of GSH. They also noted that a large
concentration was needed (lOnM) to decrease the binding by less
than half. The potential role of GSH in modulating DNA binding
mediated by the arylnitrenium ion remains to be elucidated.
D.Inhibitors
Inhibition is defined " to occur when under in vivo, ex
vivo or in vitro conditions, a given factor (endogenous or
exogenous) decreases the ability of an enzyme or an enzymatic
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system to metabolize an endogenous sxibstrate relative to control
activity" (Testa and Jenner, 1981).  Manipulation of inhibitors
is useful in defining the electron transport system within the
endoplasmic reticulum and determining the enzymatic pathways
(Schenkman and Kupfer, 1982).  Inhibitors act through a wide
variety of mechanisms which include:  competition for active
sites or cofactors of enzymes, inhibition of transport components
in multi-enzymatic systems and decreasing biosynthesis of enzymes
or their cofactors (Casarett, Doull and Amdur, 1986).
A number of chemicals demonstrated inhibitory effects in the
cytochrome P-450 system.  Carbon monoxide, for example, competes
with the endogenous ligand, molecular oxygen, for the reduced
heme moiety.  Oxygen works in a similar fashion for reactions
that occur in anaerobic environments.  The most common type of
inhibition is competition of two different substrates for the
substrate binding site of cytochrome P-450.  The degree of
inhibition is dependent on the relative affinities of xenobiotics
for the binding site.  SKF 525A, for example, is specific for
phenobarbital induced form of cytochrome P-450.  SKF 525A has
also been noted for producing a mixed type of inhibition.  The
parent molecule produces a competitive inhibition, while the
metabolites form stable complexes with cytochrome P-450 i.e.
noncompetitive inhibition (Schenkman et al, 1972). This complex
was spectrally measured  (Schenkman et al, 1972) and found to
form " a stable oxygenated cytochrome P450 metabolite ".
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The consequences of inhibition have important implications
in drug therapy as well as in elucidating the mechanisms
responsible for xenobiotic biotransformations. Many chemical
substances can cause induction and inhibition and certain
combinations can also have unpredictable and often undesirable
effects.  These processes remain complex and tedious to study.
E.Chemical Carcinogenesis
Chemical carcinogens are substances that induce neoplasms in
animals. Soot and coal tar were the first reported carcinogens
discovered in the late eighteenth century (Casarett, Doull and
Amdur, 1986). Since then many other classes and types of
chemicals have been found to be carcinogenic. These incliide
organic and inorganic chemicals, solid-state material,
cytotoxins, hormones and immunosuppressants (Searle, 1984; Arcos
et al, 1978). Although chemical carcinogens are a highly diverse
group of agents they can be identified by their ability to
produce the following adverse effects:  additional tumors not
observed in controls, earlier development of tumors than in
controls and an increase in multiplicity of tumors (Arcos et al,
1978) .
The molecular mechanism of carcinogens is subjected to and
controlled by a number of modifying factors and repair
mechanisms.  Although much of the mode of action remains unknown,
the process can be sequentially divided into a few phases
illustrated in figure 9.
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A chemical is taken up by the body and either excreted or
enzymatically converted to a reactive metabolite. The chemically
reactive metabolite is then either deactivated and excreted or
activated and able to covalently attach to cellular constituents
e.g. DNA, RNA and protein (Farber, 1981).
Covalent attachment to the DNA may be repaired, misreparied
or unchanged. Although normally DNA repair mechanisms can correct
the genotoxic event, incorrect repair can lead to mutation. Non-
cytotoxic damage occurs when the lesion is not repaired and the
covalent attachment is present as the cell replicates producing a
mutation.
Promotion to a cancer invovles proliferation.  This growth
can occur immediately after DNA alteration or may require a long
latency period (Farber, 1981).  During this process additional
alternations of DNA could occur e.g. from transpositions and
could lead to the development of a neoplastic cell. The final
stages of neoplastic development involves changes in the
phenotypic properties e.g. the transition from benign to
malignant behavior.  Although not all neoplasms undergo
qualitative changes most display abnormalities in expression of
numerous gene products.
The Somatic Mutation Theory suggests that cellular
abnormalities are passed to progeny due to genetic changes.
Therefore carcinogens may directly interact with DNA. Although
there is no proof that genetic change is the first step in
cancer, much evidence exists that favor the direct correlation
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between mutagenesis and carcinogenesis. Many carcinogens are
transformed to electrophiles that react with DNA.  For example,
adduct formation due to a specific chemical can lead to a
specific mutation in the codon which activates an oncogene
thereby producing cancer.  In this case carcinogens act as
mutagens.  DNA as the probable target for carcinogens is further
supported as defects in DNA repair as well chromosomal
abnormalities often predispose cancer development. Also,
initiated dormant tumor cells are persistent and correspond to
changes in DNA.
Because of their ubiquitous distribution and ability to
induce morphological and mutational transformation in mammalian
cells, DiPaolo et al (1983) propose that nitro-PAHs are
potentially carcinogenic.  Wislocki et al (1986) showed that
nitro-PAHs injected intraperitoneally into mice resulted in
malignant and benign tumors of the lung and liver.  Rats exposed
to diesel emissions exhibited elevated levels of adducts present
on their DNA (Wong et al, 1986).  Other short term bioassays done
to detect oncogenic transformation and tumor initiation showed
that diesel exhaust was carcinogenic (Lewtas et al, 1983).
3-NFA and 1-NP are thought to cause an increase in lung
carcinomas and malignant fibrous histiocytomas at the site of
injection (Oghaki et al, 1982).  Little information exists on the
carcinogenicity of 2-NFA.  It is postulated that like the
metabolism of 3-NFA, 2-NFA can be mediated by S9 to form an
epoxide or be reduced to an active intermediate.
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III. Materials and Methods
A.Chemicals
3-NFA was synthesized and characterized by Midwest Research
Institute (Kansas City, Mo).  3-Nitro-[14C]-fluoranthene
[specific activity 13.8 mCi/mMole, > 99% purity] was obtained
from the Midwest Research Institute (Kansas City, MO). A
certified standard ^*C toluene (4x10^ dpm/ml) and ^H toluene
(2.22x10^ dpm/ml) was purchased from New England Nuclear
(Cambridge, MA).
2-NFA was synthesized by Dr. Louise Ball from 3-
aminofluoranthene (Aldrich Chemical Company).  The purity of the
compound was verified by HPLC and thin layer chromatography
2-nitro-[^H]-fluoranthene (specific activity 439 mCi/mMole)
was purchased from Chemsyn Science Laboratories (Lenexa, KS).
The following reagents were purchased from Sigma Chemical
Company (St. Louis, MO):  glutathione, B-nicotinamide adenine
dinucleotide phosphate (reduced form) and calf thymus DNA. Other
cofactors such as flavin-adenine-dinucleotide, flavin-
mononucleotide and B-D-glucose-6-phosphate were obtained from
Boehringer Mannheim (Indianapolis, IN).
For salts and inorganic chemicals:  magnesium chloride and
potassium chloride were obtained from Fisher Scientific (Fair
Lawn, NJ).  Citric acid and sodium citrate were from EM
Scientific (Cherry Hill, NJ) and sodium chloride from
Mallinckroft (Paris, KY). Enzyme inhibitor SK&F 525-A was a
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generous gift from Smith Kline Beecham Pharmaceuticals (King of
Prussia, PA).
HPLC grade solvents such as acetone, ethyl acetate and
methanol were purchased from Baxter Healthcare Corporation
(Burdick and Jackson, Muskegon, MI) as was chloroform.  Ethyl
alcohol, 190 proof (95%) was bought from AADER Alcohol and
Chemical Company (Shelbyville, KY), A.C.S. certified grade liquid
phenol was from Fisher Scientific as was Scinti-Verse E liquid
scintillation cocktail.  1.0 M HEPES buffer, pH 7.4, was prepared
by Lineberger Tissue Culture (Chapel Hill, NC).
All S9 was obtained from Mol Tox Inc (College Park, MD).
Water for all reactions and chromatography was obtained from
a deionizing resin water system (Dacor Water System Inc., Durham,
NC).  This water system consisted of a pre-filter ( 1 um)
followed by a carbon resin, 2 deionizing resins, a post-filter (
2 um) and a reticular column.
B. Instrumentation
A Dubnoff Metabolic shaking water bath (Precision Scientific
Inc, Chicago,IL) was used in all enzyme incubations.  The
temperature was kept constant at 37°C.  Samples were spun in a
lEC Centra-8R centrifuge (International Equipment Company,
Needham Heights, MA).
HPLC was performed with a ISCO (Lincoln, NE) model 2360
gradient programmer and a model 2300 HPLC pump.  The instrument
was outfitted with a 20 micron Zorbax ODS precolumn (DuPont
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Company, Wilmington, DE) and a 250 x 4.6 mm Ultremex 5C18
analytical column (Rancho Palos Verdes, CA).  A Rheodyne 125
(Coltati, CA) injector port and a 20 micron injection loop was
used for analytical chromatography. Absorbance of the eluate at
280 nm and 245 nm was monitored with an Perkin Elmer
(Norwalk, CT) LC-85B spectrophotometer detector with an LC-85
autocontrol, dual beam variable wavelength detector with an 8 ul
flow cell capable of detecting wavelengths between 190 nm and 600
nm as well as scanning spectra of selected chromatographic
peaks.  The instrument was operated at sensitivities of 0.16 to
0.64 absorbance unit maxima. A SP-4270 integrator (Spectra
Physics, Piscataway, NJ) was used for recording single wavelength
UV absorption chromatograms.  Stop flow scanning spectra between
wavelengths 230-430 nm were recorded with Perkin Elmer (Norwalk,
CT) 561 chart recorder. The eluate from HPLC separations was
collected with a Retriever III fraction collector (Isco, Lincoln,
NB) .
The OD of DNA and protein was determined with a dual beam
Spectronic 1201 (Milton Roy Company, Rochester, NY)
spectrophotometer and UV-Vis scans were recorded on a SE 790 BBC
Goerz Metrawatt (Vienna, Austria) chart recorder.
Radioactivity was quantified with a Packard 2500 TR (Downers
Grove, IL) liquid scintillation counter.  Samples were counted in
20 ml standard glass scintillation vials with 10 mis of Scinti-
Verse E for 10 minutes on the ^'^C and ^H program. The single DPM
mode automatically constructed a quench calibration and
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calculated the disintegrations per minute (DPMs) for each sample.
Background was determined in each assay by measuring the
radioactivity of a vial which contained only 10 mis of
scintillation fluid.  A calibration curve was obtained by
preparing 8 replicates containing 10,000 DPM ^*C toluene  in 10
mis Scinti Verse E and then adding multiples of 10 ul of
nitromethane as a quenching agent. Standard samples were counted
for 10 minutes. The tSIE/AEC function was used to generate a best
A    fit calibration curve. A calibration curve for ^H was obtained in
the same manner by substituting ^E  toluene for ^'*C toluene.
C. S9 Enzyme Inctibation
S9 supernatant from the livers of Aroclor 1245 treated male
rats was stored at -80 °C until it was used. S9 (1-1.4 mg
protein) was suspended in 0.95 ml 0.1 M HEPES buffer, pH 7.4,
containing calf thymus DNA (2mg/ml 0.1 M HEPES buffer, pH 7.4).
The incubation mixture was warmed to 37 °C for 5 minutes and then
100 xiM of either ^'^C-3NFA or ^H-NFA was added. Radioactive stock
solutions consisted of the following: 10 mM 3-NFA in DMSO (9.3mg
.  3-NFA/3.765 ml DMSO) and 10 mM 2-NFA (48.83 mg of 2-NFA in 20 ml
acetone plus 30 ul ^H-2-NFA (see chemicals)).
The reaction was initiated with the addition of NADP or NAD
(3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM MgClj and
33 mM KCL. Other cofactors such as FAD and FMN (1 mg in 50 ul)
were added without a generating system.  They were added either
in addition to or instead of NADP. Other experiments were
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conducted with either conjugate GSH (1 mM) or inhibitor SKF 525A
(1 mM). These constituents were added concurrently to the
incubation mixture with NADP. After an 60 minute incvibation in a
shaking water bath the reaction was terminated by the addition of
an equal volume of phenol and vortexed.
Incubations with nitrogen were conducted in sealed test
tubes with 2 small holes in the stoppers. One hole served as a
vent and injection port.  The other hole served for introduction
of Nj gas.  The mixture was purged thoroughly with Nj by means of
a capillary pipet inserted through the inlet as it was
equilibrating to 37°C. For the first 10 minutes of the incubation
the capillary pipet was raised above the fluid and then turned
off to prevent drying of the mixture (Fig. 10).
D.Determination of Radioactivity Bound to DNA
DNA binding was estimated with a modification of the
technique developed by Jackson et al (1983). The protein was
removed by extraction with phenol (2x1 vol) followed by
extraction with chloroform:iso-amyl alcohol ( 24:1, CI) (2x1
vol). After each extraction the mixture was vortexed and
centrifuged for 10 minutes at 3000 x g. The DNA was precipitated
from the aqueous phase by addition of a spatula tip full of NaCl
and 1 volume of ice-cold EtOH, centrifuged for 5 minutes at 300 x
g and washed again. The DNA precipitated as a cloudy white clump.
The supernatant was carefully removed and the DNA was redissolved
in 1 ml 0.1 X standard saline/citrate solution ( O.l x std.
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saline/citrate consisted of 0.15 M NaCl and 0.015 M Na citrate,
pH 7.0).
50 ul were removed from the redissolved DNA and diluted in
1 ml 0.1 X std.saline/citrate and vortexed well.  The UV spectrum
of the DNA solution was scanned from 240 nm to 320 nm.  The
content of DNA was simultaneously assayed by measurement of ODj^g
and the purity of the DNA verified by examination of the
ODj^o/ODjgo ratio.  Values less than 1.7 were considered
unacceptable and disregarded.
The ^^C and 'h content of the DNA solution was determined by
liquid scintillation counting. 10 ml of Scinti Verse E was added
to the remaining dissolved DNA, inverted a few times and then
counted for 10 minutes. Blanks were run concurrently with each
assay to determine background.
E.HPLC Analysis
Although the incubation procedure was conducted fairly
similarly to the procedure previously discussed, no DNA was
added. The reaction was terminated by the addition of one volume
of ethyl-acetate/acetone ( 2:1, EA/A) and then extracted with 3 x
one volume EA/A. After every extraction the mixture was
centrifuged at 3000 x g for 15 minutes. Pooled organic extracts
were dried with a constant stream of Nj and reconstituted with
0.5 ml HPLC grade methanol and 0.5 ml deionized distilled water.
When necessary extracts were filtered through a C18 Sep Pak
cartridge (Millipore Corporation, Bedford, MA).
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_ The following HPLC gradient program was used to separate the
metabolites and the parent compound present after the incubation.
Program I: Separation of 3-NFA and 2-NFA.
0 to 10 minutes:  40% water 60% methanol
10 to 13 minutes:  40% water 60% methanol to
0% water 100% methanol
13 to 33 minutes:   0% water 100% methanol
33 to 43 minutes:  0% water 100% methanol to
40% water  60% methanol
Flow: 1 ml/min
The eluate was collected in 30 second aliquots with a fraction
collector.  10 mis of Scinti Verse E was added and the
radioactivity was determined.
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IV.Results
A.DNA Binding and the Effect of Various Cofactors
i.a-NFA
Radioactivity was detected in the isolated DNA fraction
after aerobic incubation of 3-NFA with S9 and calf thymus DNA
(fig.11, table 2.).  DNA isolated in similar conditions in the
absence of S9 contained little or no ^^C detectable above
background.  NADP was required for maximum activity in these
incubations.  This reaction was verified to be linear with
respect to time up to 60 minutes (fig. 12).  NAD also exhibited
activity but about four times less than that of NADP. The
addition of other cofactors NADP/FMN, FMN and FAD all resulted in
levels of radioactivity around background.
The binding activity under nitrogen was nearly background
regardless of the cofactor employed (fig. 13, table 3).
Nitrogen incubations showed about one-fifth less activity than
those incubations conducted under air.
2.2-NFA
Incubations with this isomer also showed significant binding
activity with S9 and under air. Unlike 3-NFA, 2-NFA seemed to
require NAD and to a lesser extent NADP for maximum activity
(fig. 14, table 4). Addition of the other cofactors yielded only
backgrovmd values. Incubations without S9 showed no significant
DNA binding levels. Incubations conducted with NADP, S9 and under
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air.were linear with respect to time for up to 60 minutes (fig.
15).
In general, activity was approximately six times less than
in incubations under nitrogen. No significant difference in
radioactivity was observed among the various cofactors expect for
NAD;  all showed little or no 'h detectable above background
(fig. 16, table 5).
6.DNA Binding and The Effect of SK&F 525A Inhibition
1.3-NPA
Aerobic incubations with cytochrome inhibitor, SK&F 525A,
indicated no significant difference in binding activity from
incubations without inhibitor (fig.17, table 6). No binding
activity was observed in anaerobic incubations with SKF 525A
(fig.18, table 7).
HPLC analysis of incubations with S9, NADP and with SKF 525A
indicated a notable decrease in metabolites formed relative to
those incubations without inhibitor (fig. 19 and fig. 20).
Quantitatively the parent compound remained fairly constant in
both types of incubations. Figures 19 and 20 are based upon the
total DPMs of an entire run. The percent of metabolites formed
per run in DPMs was approximately two times less in incubations
with inhibitor than in incubations without inhibitor.
2.2-NFA
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Similar incubations with 2-NFA showed no significant
difference in binding activity from incubations in the absence of
inhibitor.  Radioactivity in nitrogen incubations was four times
lower than that of oxygen incubations (fig. 21, table 8).
Anaerobic incubations with inhibitor had greater binding activity
than incubation without inhibitor (fig. 22, table 9).
HPLC analysis of incubations with S9, NADP and with and
without inhibitor are different. Profiles seemed to indicate less
metabolite formation when inhibitor was used than those
incubations without inhibitor ( fig. 23 and 24). Metabolite
formation was measured as a percentage of total DPMs of the run.
Figures 23 and 24 guantitatively show that while the parent
compound barely varied with or without inhibitor, the metabolites
were approximately 6 times lower with the inhibitor.
C. Glutathione Conjugation
1.3-NPA
In aerobic environments the addition of GSH to S9
incubations seem to be unable to vary the activity (fig. 17,
table 6). However, an anaerobic environment GSH seemed to
increase levels of DNA activity to four times that of background
(fig. 18, table 7).
Table 10 shows the total DPMs found in incubations conducted
without DNA and with GSH. To some reactions DNA was added to the
aqueous phase after the incubation and prior to the ethanol
extractions.  DPM values yielded less radioactivity when DNA was
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added post-incubation over the incubations with no additional
DNA.
2. 2-NPA
The addition of GSH to S9 incubations produced an apparent
two fold increase in binding activity over incubations without
GSH (fig.21, table 8). Under nitrogen, however, no radioactivity
was noted above background levels (fig. 22, table 9).
Variations in GSH incubations were conducted (table 11).
Incubations without DNA showed radioactivity. The addition of DNA
post-incubation and prior to the ethanol extractions, seemed to
decrease the radioactivity.
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V. Discussion
A. Overview
This study noted the formation of metabolites of 3-NFA and
2-NFA which bound to DNA in aerobic incubations. However,
incubations conducted under conditions most favorable for nitro
reduction resulted in insignificant levels of DNA binding.  These
results strongly suggest that the active intermediates of 3-NFA
and 2-NFA responsible for DNA binding were generated by oxidative
metabolism e.g. via epoxidation.
In similar DNA binding studies with 1-NP the results
obtained were similar to 3-NFA and 2-NFA (Ball and Lewtas, 1985).
Ball and Lewtas (1985) found that both S9 and microsomes
exhibited greatest binding in air and with NADPH. In the past
nitroreduction has been thought to be the main determinant of
mutagenicity. These results, however, confina previous studies
that propose that mutagenicity does not necessarily require
reduction of 3-NFA and 2-NFA. Although mammalian nitroreductase
activity appears to occur through the oxygen sensitive one-
electron pathway generating a nitro anion free radical
intermediate, it could also follow bacterial systems which
metabolize nitro-compounds by a two electron pathway as well
thereby bypassing the formation of the free radical (Peterson et
al, 1979).  As proposed by Ball and Lewtas (1985) the latter
route may be more efficient in generating hydroxylamine
intermediates capable of interacting with DNA, whereas the former
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can .exhibit its cytotoxicity by a superoxide which forms from
reoxidation of the nitro free radical.
B. Cytochrone P-450 Mixed Function Oxidase System
1. Cofactors
Maximal binding levels of DNA occurred under air and in the
presence of NADPH and NADH. These results indicate the
involvement of the MFO as these cofactors are indicative to this
system. Belisario et al (1990) similarly noted that NADPH was a
more efficient electron donor than NADH with 3-NFA in microsomes.
Although NADH was less effective than NADPH as an electron
donor for 3-NFA the converse held true for 2-NFA. Cytochrome bj
is unique as it can accept electrons directly from NADH and
indirectly from NADPH cytochrome P-450 reductase. This may
account for the high levels of binding noted upon addition of
NADPH to 2-NFA. The occurrence of reduction is also implied as
cytochrome bg and its reductase mediate reductive metabolism. The
exact mechanism of this enzyme is unclear as no activity was
noted in anaerobic incubations or in the presence of FMN. These
results suggest that 2-NFA may favor reduction rather than
oxidation in forming its reactive metabolite.
The addition of FMN to NADPH resulted in a decrease in DNA
binding for both isomers. This suggests that the electrons prefer
FMN over NADPH, the latter being important for DNA binding.
Belisario et al (1990) showed that nitroreduction was markedly
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stimulated by FMN. Although it is not yet clear if this flavin
acts as an electron carrier between NADPH cytochrome
P-450 and its reductase or whether the stimulated reduction
proceeds independently of this system (Kato et al, 1978) FMN
seems to be involved in nitroreduction.  These observations
further confirm the belief that DNA binding proceeds
independently of reduction.
2. SKP 525A
The addition of SKF 525A, a specific cytochrome P-450
inhibitor, showed no significant effect on DNA binding for both
3-NFA and 2-NFA under air or under nitrogen. Belisario et al
(1990) also noted the lack of inhibition in microsomal activity
when 3-NFA, SKF 525A and microsomes were incubated under
anaerobic conditions.  Similar findings were obtained with
p-nitrobezoate and S9 (Gillette and Sesame, 1964). The mechanism
of this inhibitor aids in the elucidation of these results. It is
thought that SKF 525A forms a metabolite under aerobic conditions
to cytochrome P-450 inhibiting its catalytic activity. Metabolism
of the compound would be inhibited non-competitively.  It was
also established that when substrate and inhibitor were added
simultaneously a competitive inhibition occurred (Schenkman and
Kupfer, 1982). Although both types of inhibition have been
described by various authors Schenkman et al (1972) suggested
that "the fundamental difference between the inhibitor-metabolite
cytochrome P-450 complexes is that the inhibitor-generated
40
complex stabilizes the cytochrome (in vivo and in vitro) to
inhibit the further activation of the oxygen molecule."  This can
be due to inability of the hemeprotein to accept a second
electron or to transfer it to the oxygen. SKF 525A may also be
specific for certain isozymes of cytochrome P 450. Preincubation,
therefore, allows SKF 525A to inhibit these enyzmes. The results
obtained in this study remain inconclusive as SKF 525A was not
preincubated with S9 and without substrate.
3. Conjugation
The cytochrome P-450 system can be responsible for
generating a variety of reactive metabolites which unless
inactivated by further metabolism may cause cytotoxicity.
Consequently, the potential role GSH plays in detoxification and
ultimately cancer prevention has heightened in recent years.  In
vivo animal studies, however, have been unable to conclusively
show a direct correlation of high GSH levels with a decrease in
chemically induced tumors (Sies and Ketterer, 1988) .  GSH,
therefore, remains important and is recognized and study in vitro
using DNA binding as an endpoint.
Nitro-PAHs either readily reduce to their corresponding
amines or are metabolized via epoxidation to reactive
intermediates which can react with GSH. The addition of GSH to
incubations conducted with 3-NFA under air show no noticeable
effect on the DNA binding. These results suggest that GSH does
not have an important role in the protection against reactive
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intermediates of 3-NFA. Unlike 3-NFA, 2-NFA showed a marked
increase in binding under similar conditions. This study suggests
that both DNA and GSH coprecipitated into the aqueous phase
(table 10 and 11).  Because of the size and structure of DNA, DNA
may physically engulf GSH adducts. Therefore, the radioactivity
determined may not represent that which was bound solely to DNA.
In studies conducted with another conjugating system,  UDP-
glucuronic acid, Fahl et al (1978) found that when conjugate was
in presence of ben20(a)pyrene, DNA and microsomes a significant
increase in DNA binding resulted. They explained this increase in
activity due to removal of product inhibition.  "Certain
metabolites of BP inhibit the cytochrome P-450 metabolism of both
BP and BP,7,8-dihydrodiol.  Conjugation of these metabolites with
glucuronic acid would remove the oxidase inhibitors".  They
further postulated that either quinones or phenols were the
metabolites as their levels were largely depleted by
glucuronidation.
In conclusion, the importance of GSH in substantially
decreasing DNA binding levels of 3-NFA and 2-NFA remain unclear.
In the case of 3-NFA, GSH may have bound to the metabolites but
it did not effect DNA binding. Addition of GSH to incubations
with 2-NFA seems to have increased the DNA binding. Further study
is warranted to determine what the exact role of GSH.
c. cytosolic Enzymes
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The role different cytosolic enzymes play was investigated
by using an electron donor specific for each enzyme.  Xanthine
oxidase catalyzed the reduction of niridazole (Morita et al,
1971) and the binding of 1-NP to DNA (Howard et al, 1982). These
investigators showed that activation was required in the presence
of NADH or hypoxanthine and was inhibited by allopurinol.
Significant binding was noted for both NFA isomers upon the
addition of NADH. However, the involvement of XO does not seem
likely as no binding was noted in anaerobic conditions in the
presence of NADH. Additional studies with hypoxanthine as well as
allopurinol are required in order to assess the exact
participation or lack of participation of XO.
The role of aldehyde oxidase was also superficially
examined. This cytosolic enzyme was found to reduce nitrofurazone
and 4-nitroquinoline-N-oxide to their corresponding hydroxyamino
derivatives (Wolpert et al, 1973). Belisario et al (1990)
similarly showed that AO was responsible for the cytosolic
nitroreduction of 3-NFA.  However, the range of nitro acceptors
was limited as p-nitorbenzoate and p-nitrophenol were unable to
undergo detectable reduction.  When FAD was added to both aerobic
and anaerobic incubations no noticeable DNA binding with either
isomer occurred. Although it seems likely that AO does not
catalyze the DNA binding of these nitro-PAHs, further
investigation with its other cofactor N-methylniconamide and with
specific AO inhibitors e.g. menadione and Triton X-lOO needs to
be conducted in order to confirm or exclude its participation in
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NFA metabolism. Also little information exists on the exact
metabolic mechanism of this enzyme. For example, the location of
the exact site of electron transfer to nitro acceptors is unknown
(Wolpert et al, 1973). Elucidation of AO's properties is
necessary to fully understand its part in DNA binding.
DT-diaphorase may also contribute to nitro-PAH
transformations. Belisario et al (1990) demonstrated that the
cytosolic reduction of 3-NFA was mediated by this enzyme.
Although, DT-diaphorase can accept electrons from FAD, menadione,
NADPH and NADH, the exact mechanism has yet to be fully
established. Treatment of rats with PAHs induced DT-diaphorase as
well as MFO suggesting a correlation in metabolizing ability.
More work is needed in order to confirm its involvement or lack
thereof in NFA metabolism.
D.Suggestions for Future Studies
This study indicates that adduct formation may proceed
through oxidative pathways.  Examination of the hepatic enzymes
also suggests involvement of the cytochrome P-450 mixed-function
oxidase system. Because this is in contrast to previous
investigations where nitroreductase was thought to be involved,
future knowledge is necessary in order to confirm the exact
metabolic mechanisms responsible for genotoxicity.
Confirmation of the role cytochrome P-450 plays in DNA
adduct formation is required. Isolating and identifying the DNA
adducts generated would confirm oxidative metabolism as well as
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suggest a possible route of activation e.g. epoxidation.
Identification of adducts other than dG-C8-3-AFA have not yet
been reported.
Inhibition of SKF 525A would also indicate the involvement
of cytochrome P-450. Preincubation may be needed for this
inhibitor to exert its effect. This work is being currently
conducted and may exist.
Participation of cytochrome bj and its reductase was also
suggested in this study. The exact role of cytochrome bj in DNA
binding is unclear as addition of isolated cofactors showed no
effect. Further study with this enzyme would help to elucidate
whether the activation mechanism is oxidative and which cofactors
are required. Its interaction with cytochrome P-450 would also
become clearer.
Further investigation of glutathione's ability to prevent
covalent binding needs to be assessed.  Although it seems like
GSH is ineffective in preventing DNA binding of 3-NFA, GSH seemed
to increase the binding of 2-NFA.  This increase may be due to an
artifact of the extraction procedures. Elucidation of the
mechanism would explain this increase. Other conjugating systems
should likewise should be examined in order to determine other
detoxication routes.
The exact roles the cytosolic enzymes played in DNA
formation were only superficially covered in this study.
Determination of their contribution is useful in understanding
catalysis of DNA binding. Mainly the addition of electron donors
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and-inhibitors specific for each enzyme would characterize the
their metabolic behavior.
Because 3-NFA and 2-NFA displayed differences in their
metabolism behavior, evaluation of their structural features may
aid in the elucidation of their binding ability.  Differences of
these isomers may be due to the position of the nitro group on
the fluoranthene molecule.  This slight change in geometry may be
enough to interfere with access to the active site.
The results generated from these suggested additional tests
will help to develope more criteria for understanding the
bioactivation of nitro compounds and ultimately aid in the
prediction of its genotoxicity.
E.Conclusion and Revelance to Chemical Carcinogenesis
The advent of the industrial revolution commenced the rapid
growth of a menacing gamut of pollutants many of which reside in
the air.  These compounds persevere as technology continually
advances. Our society supports these modern benefits as life is
easier and more convenient.  Lifestyles, therefore, are unlikely
to change and, consequently, these chemicals will not be
eliminated.  Because some cancer deaths are due to chemical
exposure (Chambers, 1984) these potential compounds merit
investigation.
This study examined the environmental air pollutants 3-NFA
and 2-NFA at the molecular level. Specifically, these nitro-PAHs
upon in vitro incubation with mammalian enzymes bound to DNA.
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Although adduct formation can be considered an initial step in
carcinogenesis, it is not indicative of tumor development. Also
DNA as a probable target in initiation is base mainly on
circumstantial evidence.
Nevertheless, 3-NFA and 2-NFA exhibit mutagenic and
carcinogenic behavior and deserve further examination to
determine the danger they pose to human health.  Incorporation of
the results determined from in vivo animal tests, epidemiological
human studies as well as in vitro assays will give a more
accurate representation when assessing human health risks.
^7
NO-
1-NP
NO
2-NFA 3-NFA
Fig.   1.   Structures of Nitro-PAHs
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Fig. 2   Formation of 2-NFA and 3-NFA
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Figure 7. Illustration of a Rat Hepatocyte
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Fig. 8. Examples of Glutathione Conjugation of PAHs
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a. Mechanism of Metabolism of Benzo(a)pyrene to
7,8-diol-9,10-epoxide
(Sies and Ketterer, 1988)
p-450
HO  H
b. Mechanism of Metabolism of Benz(a)anthracene to
K-Region Glutathione Conjugate
(Sies and Ketterer, 1988)
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Fig. 11. S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^'^C-3-NFA was added. Incubations were
conducted for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.
b. FMN (1 mg/50 ul) was added in conjunction to step a.
c. FMN (1 mg/50 ul) was added to initiate the reaction.
d. NAD (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 3 3 mM KCl were added to initiate the reaction.
e. FAD (1 mg/50 ul) was added to initiate the reaction.
f. No cofactors were added to these incubations.
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Fig. 12
3-NFA
Tlmecourse
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Fig. 12. S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis o.l M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37^0 the reactions was initiated with 100 uM^'•C-3-NFA, NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8
mM MgClj and 33 mM KCl. Incubations were conducted in a shakingwater bath for variable time intervals (5, 10, 15, 3 0 and 60minutes).
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Fig. 13.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^^C-3-NFA was added.
Incubations were conducted under nitrogen and for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 3 3 mM KCl were added to initiate the reaction.
b. FMN (1 mg/50 ul) was added in conjunction to step a.
c. FMN (1 mg/50 ul) was added to initiate the reaction.
d. NAD (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.
e. FAD (1 mg/50 ul) was added to initiate the reaction.
f. No cofactors were added to these inc\ibations.
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3-NFA
Anaerobic Incubation with Various Cofactors
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Fig. 13. S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes ofequilibration to 37°C 100 uM ^^C-3-NFA was added.
Incubations were conducted under nitrogen and for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgCl2 and 33 mM KCl were added to initiate the reaction.b. FMN (1 mg/50 ul) was added in conjunction to step a.
c. FMN (1 mg/50 ul) was added to initiate the reaction.
d. NAD (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClg and 33 mM KCl were added to initiate the reaction.e. FAD (1 mg/50 ul) was added to initiate the reaction.
f. No cofactors were added to these incubations.
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Fig. 14. S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes ofequilibration to 37°C 100 uM ^H-2-NFA was added. Incubations were
conducted for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.b. FMN (1 mg/50 ul) was added in conjunction to step a.
c. FMN (1 mg/50 ul) was added to initiate the reaction.
d. NAD (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.e. FAD (1 mg/50 ul) was added to initiate the reaction.
f. No cofactors were added to these incubations.
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Fig. 15. S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymusDNA (2 mg/ml, O.l M HEPES, pH 7.4). After 5 minutes ofequilibration to 37°C the reactions was initiated with 100 uM ^-
H-2-NFA, NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8
mM MgClj and 33 mM KCl. Incubations were conducted in a shakingwater bath for variable time intervals (5, 10, 15, 3 0 and 60minutes).
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Fig. 16.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^H-2-NFA was added.
Incubations were conducted under nitrogen and for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgCl2 and 3 3 mM KCl were added to initiate the reaction.
b. FMN (1 mg/50 ul) was added in conjunction to step a.
c. FMN (1 mg/50 ul) was added to initiate the reaction.
d. NAD (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.
e. FAD (1 mg/50 ul) was added to initiate the reaction.
f. No cofactors were added to these incubations.
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Fig. 17.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^^C-3-NFA was added. Incubations were
conducted for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.
b. SKF 525A (1 mM) was added in conjunction to step a.
c. GSH (1 mM) was added in conjunction to step a.
d. No cofactors were added to these incubations.
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Fig.18.   S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^^C-3-NFA was added.
Incubations were conducted under nitrogen and for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 3 3 mM KCl were added to initiate the reaction.
b. SKF 525A (1 mM) was added in conjunction to step a.
c. GSH (1 mM) was added in conjunction to step a.
d. No cofactors were added to these incubations.
66
<
Q
o
cl
Fig.   18
ͣ3-NFA
Anaerobic Incubation with SKF 525A and GSH
300
250-
200-
150
o    100
<
u
(U
^     50
0
Incubation conditions:
a
b
NADP
NADP,SKF 525
VZZ  NADP,GSH ^
^  no cofactors ^
^ ^^
vy\
4/
ͣS9 ͣS9
Fig.18.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^'^C-3-NFA was added.
Incubations were conducted under nitrogen and for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 3 3 mM KCl were added to initiate the reaction.
b. SKF 525A (1 mM) was added in conjunction to step a.
c. GSH (1 mM) was added in conjunction to step a.
d. No cofactors were added to these incubations.
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Fig. 19. Profile of Extractable Metabolites of
3-NFA Incubated with S9 in the Presence of SKF 525A
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Fig. 19. S9 (1 mg/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis 0.1 M HEPES^H 7.4. After equilibration
to 370C the reaction was initiate with 100 um KC-3-NFA, NADP
(3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM MgCl2, 33 mM
KC1 and SKF 525A (1 mM).
a. HP1C was used to seperate the metabolites at 280 nm,
b. The eluate was collected in 30 second aliquots. Radioactivity
was measured in DPMs.
DPMs:
Total run  Metabolites    Parent compound
94,861      4,564 (4%)*     85,345 (89%)*
*=% radioactivity present/entire run.
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Fig. 20. Profile of Extractable Metabolites of
3-NFA Incubated with S9 in the Absence of SKF 525A
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Fig.20. S9 (1 mg/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis 0.1 M HEPES,pH 7.4. After equilibrationto 37°C the reaction was initiate with 100 um ^'^C-3-NFA, NADP
(3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM MgClj, and
33 mM KCl.
a. HPIC was used to separate the metabolites at 280 nm.
b. The eluate was collected in 3 0 second aliquots. Radioactivity
was measured in DPMs.
DPMs:
Total run   Metabolites     Parent compound
86,041      6,883 (8%)*     74,855 (87%)*
*=% radioactivity present/entire run.
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Fig. 21.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymus
DNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes of
equilibration to 37°C 100 uM ^H-2-NFA was added. Incubations were
conducted for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM
MgClj and 33 mM KCl were added to initiate the reaction.
b. SKF 525A (1 mM) was added in conjunction to step a.
c. GSH (1 mM) was added in conjunction to step a.
d. No cofactors were added to these incubations.
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Fig.22.  S9 (1 mg/ml) from Aroclor 1254 treated male rats was
suspended in 0.95 mis 0.1 M HEPES,pH 7.4 containing calf thymusDNA (2 mg/ml, 0.1 M HEPES, pH 7.4). After 5 minutes ofequilibration to 37 C 100 uM ^H-2-NFA was added.
Incubations were conducted under nitrogen for 60 minutes.
a. NADP (3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mMMgCl2 and 33 mM KCl were added to initiate the reaction.b. SKF 525A (1 mM) was added in conjunction to step a.
c. GSH (1 mM) was added in conjunction to step a.
d. No cofactors were added to these incubations.
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Fig. 23. Profile of Extractable Metabolites of2-NFA Incubated with S9 in the Presence of SKF 525A
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Fig. 23. S9 (1 mg/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis 0.1 M HEPES,pH 7.4. After equilibrationto 37°C the reaction was initiate with 100 um ^H-2-NFA, NADP
(3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM MgCl,, 33 mMKCl and SKF 525A (1 mM).
a. HPIC was used to seperate the metabolites at 254 nm.
b. The eluate was collected in 30 second aliquots. Radioactivitywas measured in DPMs.
DPMs:
Total run  Metabolites    Parent compound
507,901     45,711 (9%)*    345,373 (68%)*
*=% radioactivity present/entire run.
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Fig. 24. Profile of Extractable Metabolites of
2-NFA Incubated with S9 in the Absence of SKF 525A
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Fig. 24. S9 (1 mg/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis 0.1 M HEPES,pH 7.4. After equilibration
to 37°C the reaction was initiate with 100 um ^H-2-NFA, NADP
(3.06 mg/ml), glucose-6-phosphate (1.41 mg/ml), 8 mM MgClg, and
33 mM KCl.
a. HPIC was used to seperate the metabolites at 254 nm.
b. The eluate was collected in 30 second aliquots. Radioactivity-
was measured in DPMs.
DPMs:
Total run  Metabolites    Parent compound
305,498     124,923 (41%)*  189,394 (62%)*
*=% radioactivity present/entire run.
Table 1. List of Enzyme  Systems
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ENZYME
Cytochrome P4 50
Cytochrome be
OX/RED
oxidative
reductive
reductive
COFACTORS
NADP, O2
NADP, Nj
FMN,FAD or
NADP
INHIBITORS
SKF 525A,CO
02,SKF 525A?
N,
Xanthine oxidase   reductive
Aldehyde oxidase   reductive
DT-diaphorase reductive
hypoxanthine
NAD,N2
allopurinol
FAD,N2 menadioneN^-methlynicotinamide
NADP,FAD ?
menadione
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Table 2
3-NFA:  Aerobic Incubations with Various Cofactors
Incubation conditions :
NADP,S9 NADP,— NADP,S9 NADP,— FMN,S9 FMN,— NAD,S9  NAD,—
FMN     FMN
43.64
32.14
16.39
1044.73^ 11 .83 29.89 9.11 21. 03 6. 93 513. 44
800.25 11 .05 28.1 9.59 24 .98 4 .81 133 .7
1698.25 12 .71 79.1 16.76 33 .85 4 .39 396 .92
1023.98 15.18
49.83
25.68
22.44
17.36
15.34
25.28
24.67
7.8
29.22
16 .97 5 .43 227 .29
Average=
1141.80 11. 86 30.82 16.19 63 .62 5 .39 317 .84
Standard deviation=
335.26 0. 68 18.69 8.23 6 .25 0 .96 147 ,16
30.72
11.17
* For description of incubations see fig. 11.
a Results are presented as pmole bound/mg DNA.
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Table 2
3-NFA:  Aerobic Incubations with Various Cofactors
Incubation conditions :
FAD,S9 FAD,—   —,S9  —,—
12.63'' 5.43 81.03 21.05
29.5 3.8 128.78 15.77
24.36 4.84 167.72 29.41
3.84 42.89 11.63
20.41 20.43
19.78 25,76
21.34 8.81
37.55 3.9
65.19 4.1
13.14 5.78
49.85 7.02
65.69 7.4
78.9 8.03
73.93 6.33
30.94 5.4
68.2 4.8
99.7 9.57
94.7 9.71
67.16 15.12
40.21 10.7
37.82 4.5
5.9
4.67
5.34
Average =
2.53    4.48   34.56   7.15
Standard deviation=
7.06    0.69   24.07   2.83
*  For description of  incubations  see  fig.   11.
a Results are presented as pitiole bound/mg DNA.
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Table 3
3-NFA:  Anaerobic Incubations with Various Cofactors
Incubation conditions :
NADP,S9 NADP,— NADP,S9 NADP,— FMN,S9 FMN,— NAD,S9  NAD,—
FMN     FMN
25.62 13.45 16.38  8.96
13.93  11.6 12.99  9.94
47.7 19.61 19.11  12.55
18.99 18.7 16.8   12.98
36.53 9.52    15.6   22.55
35.68 8.67 15.75
49.56^ 3.74 14.93 9.09
27.21 4.17 22.79 7.36
18.51 3.36 35.27 7.84
19.03 4.19 32.12 9.84
13.43 21.4 16.72
16.58 26.31 19.56
37.31
Average=
25.95 3.87 25.47 11.74
Standard deviation=
12.16 0.34 6.78 4.67
29.74    13.59    16.11  13.40
11.45     4.22     1.81   4.82
* For description of incubations see fig. 13.
a Results are presented as pinole bound/mg DNA.
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Table 3
3-NFA:  Anaerobic Incubations with Various Cofactors
Incubation conditions :
FAD,S9 FAD,—   —,S9  —,—
24 47^ 4. 91 41.75 9.93
6 87 4 .81 24.88 15.12
14 .65 10 .97 34.36 13.00
12 28 11 .42 36.6 5.57
6 42 5 .39 20.87 11.98
5 98 4 .29 12.66
18.46
41.68
14.23
15.75
57.47
40.02
29.23
15.57
18.8
20.77
39.94
27.72
18.86
10.27
4.04
2.64
21.74
7.8
9.63
10.62
7.78
3.34
6.19
8.01
11.81
11.78
6.07
11.65
3.96
8.43
9.97
2.81
1.02
Average =
11.78  6.97    27.87  8.61
Standard deviation=
6.53  3.01    12.03  4.50
* For description of incubations see fig. 13.
a Results are presented as pmole bound/mg DNA.
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Table 4
2-NFA:  Aerobic Incubations with Various Cofactors
Incubation conditions :
NADP,S9 NADP,— NADP,S9 NADP,— FMN,S9 FMN,— NAD,S9  NAD,—
FMN     FMN
0.849^ 0.045  0.245 0.085 0.060 0.016 1.08 0.11
0.518 0.053  0.143 0.203 0.080 0.046 1.03 0.13
0.700 0.020  0.176 0.092 0.050 0.051 1.19 0.156
0.201 0.081 0.061 0.056
0.273 0.060 0.008
0.124 0.070 0.008
Averagf
0.69
Standa]
2=
0.01   0.19
rd deviation=
0.12 0.06 0.03 1.10 0.13
0.14 0.04   0.05 0.05 0.01 0.02 0.07 0.02
* For description of incubations see fig. 14.
a Results are presented as pmole bound/mg DNA.
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Table 4
2-NFA:  Aerobic Incubations with Various Cofactors
Incubation conditions :
FAD,S9 FAD,—   —,S9  —,—
0.021^0.096
0.09      0.065
0.04      0.13
0.71 0,
0,
0,
0.193
0.123
0.300
14
063
11
0.018
0.403
0.118
0.23
0.153
0.17
0.11
0.02
0.07
0.43
0.26
0.1
0.06
0.06
0.127
0.11
0.332
0.117
0.213
0.186
0.079
0.159
0.097
0.11
0.13
0.08
0.17
0.056
0.036
0.088
0.043
0.043
0.06
0.138
0.023
0.360
0.042
0.049
0.057
0.07
0.03
0.24
0.028
0.058
0.053
0.008
0.041
0.044
0.047
0.15
0.035
0.037
0.052
Average =
0.06  0.10     0.154  0.06
Standard deviation=
0.03  0.03     0.10   0.05
*  For description of  incubations  see  fig.   14.
a Results  are presented as pinole bound/mg DNA.
80
Table 5
2-NFA:  Anaerobic Incubations with Various Cofactors
Incubation conditions :
NADP,S9 NADP,— NADP,S9 NADP,— FMN,S9 FMN,— NAD,S9  NAD,—
FMN     FMN
0 172^ 0.108 0.126 0.018 0.053 0.019 0.127 0.058
0 216 0.142 0.076 0.019 0.076 0.031 0.130 0.078
0 264 0.135 0.222 0.044 0.023 0.059 0.244 0.194
0 194 0.052 0.127 0.036 0.05 0.058 0.182 0.07
0 129 0.028 0.167 0.028 0.089 0.068 0.396 0.38
0.066 0.121
0.118
0.154 0.349 0.142
Average=
0.20     0.09  0.14 0.04 0.08 0.06 0.24 0.16
Standard deviation=
0.04     0.05  0.05 0.02 0.03 0.04 0.10 0.12
* For description of incubations see fig. 16.
a Results are presented as pmole bound/mg DNA.
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Table 5
2-NFA:  Anaerobic Incubations with Various Cofactors
Incubation conditions :
FAD,S9 FAD,—   —,S9  —,—
0.08" 0. 04 0.097 0.03
0.03  0 .04 0.11 0.05
0.14  0 03 0.13 0.03
0.18  0 .03 0.08 0.04
0.07  0 .03 0.17 0.05
0.04 0.097 0.044
0.066 0.047
0.062 0.15
0.099 0.035
0.027 0.037
0.174 0.052
0.088 0.035
0.41 0.153
0.353 0.094
0.314 0.144
0.100 0.070
0.176 0.060
0.760 0.049
0.980 0.059
0.110 0.029
0.241 0.089
0.180 0.110
0.131 0.036
0.053 0.161
0.055 0.081
0.132 0.028
0.116 0.031
0.113 0.041
0.096 0.034
0.163
0.217
0.094
0.112
0.143
Average ==
0.09  0 .03 0.18 0.06
Standard deviation=
0.05  0 .00 0.19 0.04
* For description of incubations see fig. 16.
a Results are presented as pinole bound/mg DNA.
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Table 6
3-NFA:  Aerobic incubations with SKF 525A and gsh
Incubation conditions :
NADP,S9 NADP,— NADP,S9  NADP,—  NADP,S9 NADP,—  —,S9  —,—
SKF 525A SKF 525A  GSH    GSH
1176.42 11.46 81.03  21.05
785.74 19.27 128.78  15.77
1158.65 37.37 167.37  29.41
1468.93 17.91 11.63
802.34 30.93 20.43
1519.34 20.41 25.76
Average=
1141.80  11.86  1425.29  31.67    1151.95 22.89 125.84  20.68
Standard deviation=
335.26   0.68   420.75  18.07     286.42  8.65 35.45  5.89
* For description of incubations see fig. 17.
a Results are presented as pmole bound/mg DNA.
1044 73^ 11.83 1929.67 29.76
800 25 11.05 1259.7 14.84
1698 .25 12.71 1822.83 61.58
1023 98 762
1352.23
20.51
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49.56^ 3.74
27.21 4.17
18.51 3.36
19.03 4.19
13.43
15.58
Table 7
3-NFA:  Anaerobic Incubations with SKF 525A and GSH
Incubation conditions :
NADP,S9 NADP,— NADP,S9  NADP,—  NADP,S9 NADP,—  —,S9  —,—
SKF 525A SKF 525A  GSH    GSH
13.73    24.08     192.64  12.64   26.81 6.38
15.79    19.50     189.35  12.31   53.54 11.46
14.70    14.22     333.55   6.96   16.43 11.48
8.94     136.59  13.96   17.06 3.29
19.05     311.08   7.58   14.83 6.38
9.4      161.81  11.61   30.53 8.76
28.95 15.94
25.61 13.89
47.93 9.74
23.73 12.75
19.09 15.48
18.46 4.04
12.66 2.04
21.74
7.8
Average=
25.95    3.87   14.74   15.87     220.79 10.84    25.82 10.08
Standard deviation^
12.16    0.34    0.84    5.53      74.42  2.63    11.94 5.21
* For description of incubations see fig. 18.
a Results are presented as pmole bound/mg DNA.
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Table 8
2-NFA:  Aerobic Incubations with SKF 525A and GSH
Incubation conditions :
NADP,S9 NADP,— NADP,S9  NADP,—  NADP,S9 NADP,—  —,S9  —,—
SKF 525A SKF 525A  GSH    GSH
0.849^  0.045  0.779    0.104 2.95 0.056    0,41   0.153
0.518   0.053  0.715    0.162 2.1 0.049    0.353  0.094
0.700   0.020  0.955    0.0149 1.75 0.054    0.314  0.144
Average=
0.69    0.04   0.82     0.14 2.27 0.050    0.36   0.13
Standard deviation=
0.14    0.01   0.10     0.02 0.05 0.00     0.04   0.03
* For description of incubations see fig. 21.
a Results are presented as pinole bound/mg DNA.
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Table 9
2-NFA:  Anaerobic Incubations with SKF 525A and GSH
Incubation conditions*:
NADP,S9 NADP,— NADP,S9  NADP,—  NADP,S9 NADP,—  —,39  —,—
SKF 525A SKF 525A  GSH    GSH
0.172' 0.108  0.926 0.067
0.216 0.142 0.713 0.149
0.264 0.135 0.242 0.082
0.194 0.052 0.143 0.144
0.129 0.028 0.625 0.074
0.582 0.05
Average=
0.20   0.09  0.54    0.09
Standard deviation=
0.04        0.05      0.27 0.04
0.233      0.079
0.133      0.102
0.693
0.331
0.667
0.53
0,
0,
0,
146
052
077
0.43  0.09
0.21  0.03
0.19
0.07
0.135
0.116
0.194
0.19
0.07
0.135
0.116
0.194
0.096
0.053
0.055
0.132
0.116
0.12
0.05
0.052
0.058
0.047
0.056
0.065
0.042
0.049
0.044
0.066
0.055
054
099
029
0.089
0.108
0.036
0.06
0.02
0.
0,
0.
* For description of incubations see fig. 22.
a Results are presented as pmole bound/mg DNA.
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TABLE 11
Recovery of GSH Conjugates of 2-NFA in the Presence of DNA
-DNA^ +DNA'''"
(DPMs)'^ (DPMs)
in aqueous phase with DNA
Incubation Conditions:
GSH,NADP,S9,02 5,599 436
GSH,NADP,~,02
--'--'^2        H
43
__e
81
__e
--, — ,39,02'^ __e 41
a. S9 (Img/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis O.IM HEPES,pH 7.4. After
equilibration to 37°C the reaction was initiate
with 100 urn 'h-2-NFA, NADP (3.06 mg/ml), glucose-
6-phosphate (1.41 mg/ml), 8 mM MgClj, 33 mM KCl and
1 mM GSH.Incubations were conducted for 60 minutes.
b. DNA (2 mg/ml) in 0.1 M HEPES, pH 7.4 was added
to the aqueous layer post incubation but prior to
the ethanol extractions. DNA was then recovered in the
manner previously described in Materials and Methods.
c. Total DPMs in aqueous phase after the ethanol
extractions.
d. Control incubations.
e. These values were not determined.
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TABLE 10
Recovery of GSH Conjugates of 3-NFA in the Presence of DNA
a
Incubation Conditions:
GSH,NADP,S9,02
GSH,NAD?,—,0,—   —  0^ 2
--,--,39,02"^
-DNA
(DPMS)''
in aqueous phase
74,554
1,455
+DNA^'''
(DPMs)
with DNA
6,881
61
354
211
a. S9 (Img/ml) from Aroclor 1254 treated male rats
was suspended in 0.95 mis 0.1 M HEPES,pH 7.4. After
equilibration to 37°C the reaction was initiate
with 100 urn ^'^C-3-NFA, NADP (3.06 mg/ml) , glucose-
6-phosphate (1.41 mg/ml), 8 mM MgClj, 33 mM KCl and
1 mM GSH. Incubations were conducted for 60 minutes.
b. DNA (2 mg/ml) in 0.1 M HEPES, pH 7.4 was added
to the aqueous layer post incubation but prior to
the ethanol extractions. DNA was then recovered in the
manner previously described in Materials and Methods.
c. Total DPMs in aqueous phase after the ethanol
extractions.
d. Control incubations.
e. These values were not determined.
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